Ατορβαστατίνη (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ατορβαστατίνη" in Greek language version.

refsWebsite

Global rank Greek rank

48nih.gov

4^th place

41doi.org

2^nd place

3^rd place

13archive.org

6^th place

5^th place

3web.archive.org

1^st place

2drugs.com

399^th place

130^th place

2clincalc.com

3,912^th place

594^th place

2fda.gov

447^th place

368^th place

1books.google.com

3^rd place

6^th place

1google.com

163^rd place

168^th place

1ijcem.com

low place

1webmd.com

1,169^th place

603^rd place

1mayoclinic.org

1,610^th place

485^th place

1ft.com

210^th place

362^nd place

1fortune.com

433^rd place

801^st place

1illinois.edu

1,349^th place

1,975^th place

1nytimes.com

7^th place

29^th place

1wsj.com

79^th place

247^th place

1crainsnewyork.com

6,865^th place

low place

1cnn.com

28^th place

93^rd place

archive.org

«Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial». The Journal of Pediatrics 143 (1): 74–80. July 2003. doi:10.1016/S0022-3476(03)00186-0. PMID 12915827. https://archive.org/details/sim_journal-of-pediatrics_2003-07_143_1/page/74.
«Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor». Arteriosclerosis, Thrombosis, and Vascular Biology 15 (5): 678–82. May 1995. doi:10.1161/01.ATV.15.5.678. PMID 7749881. https://archive.org/details/sim_arteriosclerosis-thrombosis-and-vascular-biology_1995-05_15_5/page/678.
«Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia». Arteriosclerosis, Thrombosis, and Vascular Biology 17 (8): 1527–31. August 1997. doi:10.1161/01.ATV.17.8.1527. PMID 9301631. https://archive.org/details/sim_arteriosclerosis-thrombosis-and-vascular-biology_1997-08_17_8/page/1527.
«Analysis of efficacy and safety in patients aged 65–75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS)». Diabetes Care 29 (11): 2378–84. November 2006. doi:10.2337/dc06-0872. PMID 17065671. https://archive.org/details/sim_diabetes-care_2006-11_29_11/page/2378.
«High-dose statins should only be used in atherosclerotic strokes». Stroke 43 (7): 1994–5. July 2012. doi:10.1161/STROKEAHA.111.633339. PMID 22581818. https://archive.org/details/sim_stroke_2012-07_43_7/page/1994.
«Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)». JAMA 285 (19): 2486–97. May 2001. doi:10.1001/jama.285.19.2486. PMID 11368702. https://archive.org/details/sim_jama_2001-05-16_285_19/page/n79.
«Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines». Circulation 110 (2): 227–39. July 2004. doi:10.1161/01.CIR.0000133317.49796.0E. PMID 15249516. https://archive.org/details/sim_circulation_2004-07-13_110_2/page/n158.
«Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy». Clinical Pharmacology and Therapeutics 79 (6): 532–9. June 2006. doi:10.1016/j.clpt.2006.02.014. PMID 16765141. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2006-06_79_6/page/532.
«Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients». American Journal of Cardiology 92 (6): 670–6. September 2003. doi:10.1016/S0002-9149(03)00820-8. PMID 12972104. https://archive.org/details/sim_american-journal-of-cardiology_2003-09-15_92_6/page/n33.
«Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study». Journal of Clinical Pharmacology 33 (3): 226–9. March 1993. doi:10.1002/j.1552-4604.1993.tb03948.x. PMID 8463436. https://archive.org/details/sim_journal-of-clinical-pharmacology_1993-03_33_3/page/226.
«Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin». Clinical Pharmacology and Therapeutics 68 (4): 391–400. October 2000. doi:10.1067/mcp.2000.110537. PMID 11061579. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2000-10_68_4/page/391.
«Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites». Clinical Pharmacology and Therapeutics 78 (2): 154–67. August 2005. doi:10.1016/j.clpt.2005.04.007. PMID 16084850. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2005-08_78_2/page/154.
«Effects of vitamin D supplementation in atorvastatin-treated patients: a new drug interaction with an unexpected consequence». Clinical Pharmacology and Therapeutics 85 (2): 198–203. February 2009. doi:10.1038/clpt.2008.165. PMID 18754003. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2009-02_85_2/page/198.

books.google.com

Fischer, Jnos· Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. σελ. 473. ISBN 9783527607495.

clincalc.com

«The Top 300 of 2020». ClinCalc. Ανακτήθηκε στις 26 Φεβρουαρίου 2020.
«Atorvastatin - Drug Usage Statistics». ClinCalc. 23 Δεκεμβρίου 2019. Ανακτήθηκε στις 7 Απριλίου 2020.

cnn.com

edition.cnn.com

«Lipitor loses patent, goes generic». CNN. 30 November 2011. https://edition.cnn.com/2011/11/30/health/lipitor-generic/index.html. Ανακτήθηκε στις 18 November 2012.

crainsnewyork.com

«Lipitor becomes world's top-selling drug». Crain's New York Business via Associated Press. 28 Δεκεμβρίου 2011. Ανακτήθηκε στις 24 Νοεμβρίου 2011.

doi.org

dx.doi.org

«Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial». The Journal of Pediatrics 143 (1): 74–80. July 2003. doi:10.1016/S0022-3476(03)00186-0. PMID 12915827. https://archive.org/details/sim_journal-of-pediatrics_2003-07_143_1/page/74.
«Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial». JAMA 295 (13): 1556–65. April 2006. doi:10.1001/jama.295.13.jpc60002. PMID 16533939.
«Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor». Arteriosclerosis, Thrombosis, and Vascular Biology 15 (5): 678–82. May 1995. doi:10.1161/01.ATV.15.5.678. PMID 7749881. https://archive.org/details/sim_arteriosclerosis-thrombosis-and-vascular-biology_1995-05_15_5/page/678.
«Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia». JAMA 275 (2): 128–33. January 1996. doi:10.1001/jama.1996.03530260042029. PMID 8531308.
«The anti-atherosclerotic effects of lipid lowering with atorvastatin in patients with hypercholesterolemia». Journal of Atherosclerosis and Thrombosis 13 (4): 216–9. August 2006. doi:10.5551/jat.13.216. PMID 16908955.
«Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia». Arteriosclerosis, Thrombosis, and Vascular Biology 17 (8): 1527–31. August 1997. doi:10.1161/01.ATV.17.8.1527. PMID 9301631. https://archive.org/details/sim_arteriosclerosis-thrombosis-and-vascular-biology_1997-08_17_8/page/1527.
«Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial». Lancet 361 (9364): 1149–58. April 2003. doi:10.1016/S0140-6736(03)12948-0. PMID 12686036.
«Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis». BMJ 326 (7404): 1423–0. June 2003. doi:10.1136/bmj.326.7404.1423. PMID 12829554.
«Prediction of coronary heart disease using risk factor categories». Circulation 97 (18): 1837–47. May 1998. doi:10.1161/01.CIR.97.18.1837. PMID 9603539.
«Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)». The American Journal of Cardiology 81 (5): 582–7. March 1998. doi:10.1016/S0002-9149(97)00965-X. PMID 9514454.
«Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial». Lancet 364 (9435): 685–96. 2004. doi:10.1016/S0140-6736(04)16895-5. PMID 15325833.
«Analysis of efficacy and safety in patients aged 65–75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS)». Diabetes Care 29 (11): 2378–84. November 2006. doi:10.2337/dc06-0872. PMID 17065671. https://archive.org/details/sim_diabetes-care_2006-11_29_11/page/2378.
«Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia». Diabetes, Obesity & Metabolism 2 (6): 355–62. December 2000. doi:10.1046/j.1463-1326.2000.00106.x. PMID 11225965.
«Update on the efficacy of statin treatment in acute coronary syndromes». European Journal of Clinical Investigation 44 (5): 501–15. May 2014. doi:10.1111/eci.12255. PMID 24601937.
«High-dose statins should only be used in atherosclerotic strokes». Stroke 43 (7): 1994–5. July 2012. doi:10.1161/STROKEAHA.111.633339. PMID 22581818. https://archive.org/details/sim_stroke_2012-07_43_7/page/1994.
«Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis». American Journal of Kidney Diseases 67 (6): 881–92. June 2016. doi:10.1053/j.ajkd.2016.01.016. PMID 26905361.
«Preoperative Statin Treatment for the Prevention of Acute Kidney Injury in Patients Undergoing Cardiac Surgery: A Meta-Analysis of Randomised Controlled Trials». Heart, Lung & Circulation 26 (11): 1200–1207. November 2017. doi:10.1016/j.hlc.2016.11.024. PMID 28242291.
«Comparative Efficacy of Statins for Prevention of Contrast-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease: A Network Meta-Analysis». Angiology 70 (4): 305–316. April 2019. doi:10.1177/0003319718801246. PMID 30261736.
«Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials». International Urology and Nephrology 50 (6): 1085–1095. June 2018. doi:10.1007/s11255-018-1814-0. PMID 29404930. http://www.ijcem.com/files/ijcem0015476.pdf.
«Beneficial effect of statin on preventing contrast-induced acute kidney injury in patients with renal insufficiency: A meta-analysis». Medicine 99 (10): e19473. March 2020. doi:10.1097/MD.0000000000019473. PMID 32150109.
«Meta-analysis of rosuvastatin efficacy in prevention of contrast-induced acute kidney injury». Drug Design, Development and Therapy 12: 3685–3690. October 2018. doi:10.2147/DDDT.S178020. PMID 30464400.
«Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)». JAMA 285 (19): 2486–97. May 2001. doi:10.1001/jama.285.19.2486. PMID 11368702. https://archive.org/details/sim_jama_2001-05-16_285_19/page/n79.
«Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines». Circulation 110 (2): 227–39. July 2004. doi:10.1161/01.CIR.0000133317.49796.0E. PMID 15249516. https://archive.org/details/sim_circulation_2004-07-13_110_2/page/n158.
«Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy». Clinical Pharmacology and Therapeutics 79 (6): 532–9. June 2006. doi:10.1016/j.clpt.2006.02.014. PMID 16765141. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2006-06_79_6/page/532.
«Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors». Clinical Pharmacokinetics 41 (5): 343–70. 2002. doi:10.2165/00003088-200241050-00003. PMID 12036392.
«Statins and risk of new-onset diabetes mellitus». Circulation 126 (18): e282–4. October 2012. doi:10.1161/CIRCULATIONAHA.112.122135. PMID 23109518.
«Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis». BMC Medicine 12: 51. March 2014. doi:10.1186/1741-7015-12-51. PMID 24655568.
«Risks associated with statin therapy: a systematic overview of randomized clinical trials». Circulation 114 (25): 2788–97. December 2006. doi:10.1161/CIRCULATIONAHA.106.624890. PMID 17159064.
«Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients». American Journal of Cardiology 92 (6): 670–6. September 2003. doi:10.1016/S0002-9149(03)00820-8. PMID 12972104. https://archive.org/details/sim_american-journal-of-cardiology_2003-09-15_92_6/page/n33.
«Do statins beneficially or adversely affect glucose homeostasis?». Current Vascular Pharmacology 8 (5): 612–31. September 2010. doi:10.2174/157016110792006879. PMID 20507274.
«Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations». PLOS ONE 15 (4): e0231883. 2020. doi:10.1371/journal.pone.0231883. PMID 32302358.
«Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study». Journal of Clinical Pharmacology 33 (3): 226–9. March 1993. doi:10.1002/j.1552-4604.1993.tb03948.x. PMID 8463436. https://archive.org/details/sim_journal-of-clinical-pharmacology_1993-03_33_3/page/226.
«Atherosclerosis in type 2 diabetes: a role for fibrate therapy?». Diabetes & Vascular Disease Research 4 (4): 368–74. December 2007. doi:10.3132/dvdr.2007.067. PMID 18158710.
«Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs». JAMA 292 (21): 2585–90. December 2004. doi:10.1001/jama.292.21.2585. PMID 15572716.
«Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin». Clinical Pharmacology and Therapeutics 68 (4): 391–400. October 2000. doi:10.1067/mcp.2000.110537. PMID 11061579. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2000-10_68_4/page/391.
«Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance». Clinical Pharmacology and Therapeutics 80 (6): 565–81. December 2006. doi:10.1016/j.clpt.2006.09.003. PMID 17178259.
«Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites». Clinical Pharmacology and Therapeutics 78 (2): 154–67. August 2005. doi:10.1016/j.clpt.2005.04.007. PMID 16084850. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2005-08_78_2/page/154.
«Effects of vitamin D supplementation in atorvastatin-treated patients: a new drug interaction with an unexpected consequence». Clinical Pharmacology and Therapeutics 85 (2): 198–203. February 2009. doi:10.1038/clpt.2008.165. PMID 18754003. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2009-02_85_2/page/198.
«Statins reduce vascular inflammation in atherogenesis: A review of underlying molecular mechanisms». International Journal of Biochemistry & Cell Biology 122: 105735. May 2020. doi:10.1016/j.biocel.2020.105735. PMID 32126319.
«Atorvastatin for lowering lipids». Cochrane Database of Systematic Reviews (3): CD008226. March 2015. doi:10.1002/14651858.cd008226.pub3. PMID 25760954.
«Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)». Lancet 344 (8934): 1383–9. November 1994. doi:10.1016/s0140-6736(94)90566-5. PMID 7968073.

drugs.com

«Atorvastatin Calcium Monograph for Professionals». Drugs.com. AHFS. Ανακτήθηκε στις 23 Δεκεμβρίου 2018.
«Atorvastatin Calcium». American Society of Health-System Pharmacists. Ανακτήθηκε στις 3 Απριλίου 2011.

fda.gov

«FDA Expands Advice on Statin Risks». U.S. Food and Drug Administration (FDA). 31 Ιανουαρίου 2014. Αρχειοθετήθηκε από το πρωτότυπο στις 18 Νοεμβρίου 2015. Ανακτήθηκε στις 24 Νοεμβρίου 2015.

accessdata.fda.gov

«Approval Letter» (PDF). U.S. Food and Drug Administration (FDA).

fortune.com

archive.fortune.com

Simons, John (20 Ιανουαρίου 2003). «The $10 Billion Pill Hold the fries, please. Lipitor, the cholesterol-lowering medication, has become the bestselling pharmaceutical in history. Here's how Pfizer did it». Fortune. Αρχειοθετήθηκε από το πρωτότυπο στις 27 Φεβρουαρίου 2020. Ανακτήθηκε στις 22 Σεπτεμβρίου 2020.

ft.com

Andrew, Jack (28 Νοεμβρίου 2009). «The fall of the world's best-selling drug». Financial Times. Ανακτήθηκε στις 24 Νοεμβρίου 2015.

google.com

Hitchings, Andrew· Lonsdale, Dagan (2014). The Top 100 Drugs e-book: Clinical Pharmacology and Practical Prescribing. Elsevier Health Sciences. σελ. 197. ISBN 978-0-7020-5515-7.

ijcem.com

«Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials». International Urology and Nephrology 50 (6): 1085–1095. June 2018. doi:10.1007/s11255-018-1814-0. PMID 29404930. http://www.ijcem.com/files/ijcem0015476.pdf.

illinois.edu

scs.illinois.edu

Hoefle, Milton L. (2000). «The Early History of Parke-Davis and Company». Bull. Hist. Chem. 25 (1): 28–34. Αρχειοθετήθηκε από το πρωτότυπο στις 2018-09-20. https://web.archive.org/web/20180920162755/http://www.scs.illinois.edu/~mainzv/HIST/bulletin_open_access/v25-1/v25-1%20p28-34.pdf. Ανακτήθηκε στις 2020-09-22.

mayoclinic.org

Mayo Clinic Staff. «Statin Side Effects: Weigh the Risks and Benefits». The Mayo Clinic. Ανακτήθηκε στις 19 Απριλίου 2014.

nih.gov

ncbi.nlm.nih.gov

«Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial». The Journal of Pediatrics 143 (1): 74–80. July 2003. doi:10.1016/S0022-3476(03)00186-0. PMID 12915827. https://archive.org/details/sim_journal-of-pediatrics_2003-07_143_1/page/74.
«Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial». JAMA 295 (13): 1556–65. April 2006. doi:10.1001/jama.295.13.jpc60002. PMID 16533939.
«Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor». Arteriosclerosis, Thrombosis, and Vascular Biology 15 (5): 678–82. May 1995. doi:10.1161/01.ATV.15.5.678. PMID 7749881. https://archive.org/details/sim_arteriosclerosis-thrombosis-and-vascular-biology_1995-05_15_5/page/678.
«Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia». JAMA 275 (2): 128–33. January 1996. doi:10.1001/jama.1996.03530260042029. PMID 8531308.
«The anti-atherosclerotic effects of lipid lowering with atorvastatin in patients with hypercholesterolemia». Journal of Atherosclerosis and Thrombosis 13 (4): 216–9. August 2006. doi:10.5551/jat.13.216. PMID 16908955.
«Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia». Arteriosclerosis, Thrombosis, and Vascular Biology 17 (8): 1527–31. August 1997. doi:10.1161/01.ATV.17.8.1527. PMID 9301631. https://archive.org/details/sim_arteriosclerosis-thrombosis-and-vascular-biology_1997-08_17_8/page/1527.
«Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial». Lancet 361 (9364): 1149–58. April 2003. doi:10.1016/S0140-6736(03)12948-0. PMID 12686036.
«Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis». BMJ 326 (7404): 1423–0. June 2003. doi:10.1136/bmj.326.7404.1423. PMID 12829554.
«Prediction of coronary heart disease using risk factor categories». Circulation 97 (18): 1837–47. May 1998. doi:10.1161/01.CIR.97.18.1837. PMID 9603539.
«Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)». The American Journal of Cardiology 81 (5): 582–7. March 1998. doi:10.1016/S0002-9149(97)00965-X. PMID 9514454.
«Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial». Lancet 364 (9435): 685–96. 2004. doi:10.1016/S0140-6736(04)16895-5. PMID 15325833.
«Analysis of efficacy and safety in patients aged 65–75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS)». Diabetes Care 29 (11): 2378–84. November 2006. doi:10.2337/dc06-0872. PMID 17065671. https://archive.org/details/sim_diabetes-care_2006-11_29_11/page/2378.
«Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia». Diabetes, Obesity & Metabolism 2 (6): 355–62. December 2000. doi:10.1046/j.1463-1326.2000.00106.x. PMID 11225965.
«Update on the efficacy of statin treatment in acute coronary syndromes». European Journal of Clinical Investigation 44 (5): 501–15. May 2014. doi:10.1111/eci.12255. PMID 24601937.
«High-dose statins should only be used in atherosclerotic strokes». Stroke 43 (7): 1994–5. July 2012. doi:10.1161/STROKEAHA.111.633339. PMID 22581818. https://archive.org/details/sim_stroke_2012-07_43_7/page/1994.
«Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis». American Journal of Kidney Diseases 67 (6): 881–92. June 2016. doi:10.1053/j.ajkd.2016.01.016. PMID 26905361.
«Preoperative Statin Treatment for the Prevention of Acute Kidney Injury in Patients Undergoing Cardiac Surgery: A Meta-Analysis of Randomised Controlled Trials». Heart, Lung & Circulation 26 (11): 1200–1207. November 2017. doi:10.1016/j.hlc.2016.11.024. PMID 28242291.
«Comparative Efficacy of Statins for Prevention of Contrast-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease: A Network Meta-Analysis». Angiology 70 (4): 305–316. April 2019. doi:10.1177/0003319718801246. PMID 30261736.
«Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials». International Urology and Nephrology 50 (6): 1085–1095. June 2018. doi:10.1007/s11255-018-1814-0. PMID 29404930. http://www.ijcem.com/files/ijcem0015476.pdf.
«Beneficial effect of statin on preventing contrast-induced acute kidney injury in patients with renal insufficiency: A meta-analysis». Medicine 99 (10): e19473. March 2020. doi:10.1097/MD.0000000000019473. PMID 32150109.
«Meta-analysis of rosuvastatin efficacy in prevention of contrast-induced acute kidney injury». Drug Design, Development and Therapy 12: 3685–3690. October 2018. doi:10.2147/DDDT.S178020. PMID 30464400.
«Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)». JAMA 285 (19): 2486–97. May 2001. doi:10.1001/jama.285.19.2486. PMID 11368702. https://archive.org/details/sim_jama_2001-05-16_285_19/page/n79.
«Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines». Circulation 110 (2): 227–39. July 2004. doi:10.1161/01.CIR.0000133317.49796.0E. PMID 15249516. https://archive.org/details/sim_circulation_2004-07-13_110_2/page/n158.
«Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy». Clinical Pharmacology and Therapeutics 79 (6): 532–9. June 2006. doi:10.1016/j.clpt.2006.02.014. PMID 16765141. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2006-06_79_6/page/532.
«Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors». Clinical Pharmacokinetics 41 (5): 343–70. 2002. doi:10.2165/00003088-200241050-00003. PMID 12036392.
«Statins and risk of new-onset diabetes mellitus». Circulation 126 (18): e282–4. October 2012. doi:10.1161/CIRCULATIONAHA.112.122135. PMID 23109518.
«Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis». BMC Medicine 12: 51. March 2014. doi:10.1186/1741-7015-12-51. PMID 24655568.
«Risks associated with statin therapy: a systematic overview of randomized clinical trials». Circulation 114 (25): 2788–97. December 2006. doi:10.1161/CIRCULATIONAHA.106.624890. PMID 17159064.
«Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients». American Journal of Cardiology 92 (6): 670–6. September 2003. doi:10.1016/S0002-9149(03)00820-8. PMID 12972104. https://archive.org/details/sim_american-journal-of-cardiology_2003-09-15_92_6/page/n33.
«Do statins beneficially or adversely affect glucose homeostasis?». Current Vascular Pharmacology 8 (5): 612–31. September 2010. doi:10.2174/157016110792006879. PMID 20507274.
«Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations». PLOS ONE 15 (4): e0231883. 2020. doi:10.1371/journal.pone.0231883. PMID 32302358.
«Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study». Journal of Clinical Pharmacology 33 (3): 226–9. March 1993. doi:10.1002/j.1552-4604.1993.tb03948.x. PMID 8463436. https://archive.org/details/sim_journal-of-clinical-pharmacology_1993-03_33_3/page/226.
«Atherosclerosis in type 2 diabetes: a role for fibrate therapy?». Diabetes & Vascular Disease Research 4 (4): 368–74. December 2007. doi:10.3132/dvdr.2007.067. PMID 18158710.
«Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs». JAMA 292 (21): 2585–90. December 2004. doi:10.1001/jama.292.21.2585. PMID 15572716.
«Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin». Clinical Pharmacology and Therapeutics 68 (4): 391–400. October 2000. doi:10.1067/mcp.2000.110537. PMID 11061579. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2000-10_68_4/page/391.
«Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance». Clinical Pharmacology and Therapeutics 80 (6): 565–81. December 2006. doi:10.1016/j.clpt.2006.09.003. PMID 17178259.
«Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites». Clinical Pharmacology and Therapeutics 78 (2): 154–67. August 2005. doi:10.1016/j.clpt.2005.04.007. PMID 16084850. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2005-08_78_2/page/154.
«Effects of vitamin D supplementation in atorvastatin-treated patients: a new drug interaction with an unexpected consequence». Clinical Pharmacology and Therapeutics 85 (2): 198–203. February 2009. doi:10.1038/clpt.2008.165. PMID 18754003. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2009-02_85_2/page/198.
«Statins reduce vascular inflammation in atherogenesis: A review of underlying molecular mechanisms». International Journal of Biochemistry & Cell Biology 122: 105735. May 2020. doi:10.1016/j.biocel.2020.105735. PMID 32126319.
«Atorvastatin for lowering lipids». Cochrane Database of Systematic Reviews (3): CD008226. March 2015. doi:10.1002/14651858.cd008226.pub3. PMID 25760954.
«Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)». Lancet 344 (8934): 1383–9. November 1994. doi:10.1016/s0140-6736(94)90566-5. PMID 7968073.

pubmedcentral.nih.gov

«Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis». BMJ 326 (7404): 1423–0. June 2003. doi:10.1136/bmj.326.7404.1423. PMID 12829554.
«Meta-analysis of rosuvastatin efficacy in prevention of contrast-induced acute kidney injury». Drug Design, Development and Therapy 12: 3685–3690. October 2018. doi:10.2147/DDDT.S178020. PMID 30464400.
«Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis». BMC Medicine 12: 51. March 2014. doi:10.1186/1741-7015-12-51. PMID 24655568.
«Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations». PLOS ONE 15 (4): e0231883. 2020. doi:10.1371/journal.pone.0231883. PMID 32302358.
«Atorvastatin for lowering lipids». Cochrane Database of Systematic Reviews (3): CD008226. March 2015. doi:10.1002/14651858.cd008226.pub3. PMID 25760954.

dailymed.nlm.nih.gov

«Lipitor- atorvastatin calcium tablet, film coated». DailyMed. Ανακτήθηκε στις 26 Φεβρουαρίου 2020.

toxnet.nlm.nih.gov

«TOXNET». toxnet.nlm.nih.gov. U.S. National Library of Medicine. Ανακτήθηκε στις 29 Μαΐου 2018.

nytimes.com

Petersen, Melody (8 February 2000). «Pfizer Gets Its Deal to Buy Warner-Lambert for $90.2 Billion». The New York Times. https://www.nytimes.com/2000/02/08/business/pfizer-gets-its-deal-to-buy-warner-lambert-for-90.2-billion.html.

web.archive.org

«FDA Expands Advice on Statin Risks». U.S. Food and Drug Administration (FDA). 31 Ιανουαρίου 2014. Αρχειοθετήθηκε από το πρωτότυπο στις 18 Νοεμβρίου 2015. Ανακτήθηκε στις 24 Νοεμβρίου 2015.
Simons, John (20 Ιανουαρίου 2003). «The $10 Billion Pill Hold the fries, please. Lipitor, the cholesterol-lowering medication, has become the bestselling pharmaceutical in history. Here's how Pfizer did it». Fortune. Αρχειοθετήθηκε από το πρωτότυπο στις 27 Φεβρουαρίου 2020. Ανακτήθηκε στις 22 Σεπτεμβρίου 2020.
Hoefle, Milton L. (2000). «The Early History of Parke-Davis and Company». Bull. Hist. Chem. 25 (1): 28–34. Αρχειοθετήθηκε από το πρωτότυπο στις 2018-09-20. https://web.archive.org/web/20180920162755/http://www.scs.illinois.edu/~mainzv/HIST/bulletin_open_access/v25-1/v25-1%20p28-34.pdf. Ανακτήθηκε στις 2020-09-22.

webmd.com

Salynn, Boyles (9 Ιανουαρίου 2012). «Statins May Raise Diabetes Risk in Older Women: Study: Middle-Aged, Older Statin Users Had More Type 2 Diabetes». WebMD Health News. Ανακτήθηκε στις 24 Νοεμβρίου 2015.

wsj.com

Winslow, Ron (24 January 2000). «The Birth of a Blockbuster: Lipitor's Route out of the Lab». The Wall Street Journal. https://www.wsj.com/articles/SB948677773420632448. Ανακτήθηκε στις 26 October 2011.